首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Applied biosafety

缩写:

ISSN:1535-6760

e-ISSN:2470-1246

IF/分区:0.5/N/A

文章目录 更多期刊信息

共收录本刊相关文章索引191
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
André de Oliveira Mendonça,Claudio Mafra André de Oliveira Mendonça
Introduction: High-containment biological laboratories (HCBLs) are specialized facilities designed for handling high-risk biological agents. The lack of data regarding the quantity, condition, and distribution of these la...
Anders Leung,Todd Cutts,Jay Krishnan Anders Leung
Introduction: Positive pressure breathing-air-fed protective suits are used in biosafety level 4 (BSL-4) containment laboratories as personal protective equipment to protect workers from high-consequence pathogens. Howeve...
Jérémy Rotzetter,Ngoc Dung Le,Flurina L Leib et al. Jérémy Rotzetter et al.
Background: Inactivation of infectious liquid waste can be performed by different means, including autoclaving or chemical inactivation. Autoclaving is most widely used, but cannot always be implemented, so that chemical ...
Paul Gulig,Scott Swindle,Mark Fields et al. Paul Gulig et al.
Introduction: Discussion of gene-modified investigational products (IPs) in clinical trials has largely focused on nucleic acid-based vectors, viral vectors, and gene-modified cellular products involving mammalian cells. ...
Amanda Brady,Maggie Tomaszewski,Taylor M Garrison et al. Amanda Brady et al.
Introduction: Yersinia pestis is the gram-negative, facultative intracellular bacterium that causes the disease known as plague. Due to the risk for aerosol transmission, a low infectious dose, and the acute and lethal na...
Rhys Tancock-Jones,Brett Cole,Jeremy Martens et al. Rhys Tancock-Jones et al.
Introduction: Cephalosporins can trigger hypersensitivity reactions in certain individuals. Consequently, strict regulations restrict the production of non-beta-lactam substances during or after cephalosporin manufacturin...
Nicole E Wheeler,Craig Bartling,Sarah R Carter et al. Nicole E Wheeler et al.
Objective: DNA synthesis companies screen orders to detect controlled sequences with misuse risks. Assessing screening accuracy is challenging owing to the breadth of biological risks and ambiguities in risk definitions. ...
Laura Adam,George H McArthur th Laura Adam
Background: The advent of easy-to-use benchtop DNA synthesizers has ushered in a transformative era in biotechnology, extending the capabilities of DNA synthesis to nonspecialists. However, this revolution in access to th...
Piers D Millett Piers D Millett
Introduction: Tools to screen orders submitted to companies synthesizing nucleic acids or machines that can synthesize them are vital to help ensure the building blocks for pathogens, toxins, or other biotechnology that c...
Bryan T Gemler,Chiranjit Mukherjee,Patrick A Fullerton et al. Bryan T Gemler et al.
Objectives: The primary objectives of this study were to develop an objective nucleic acid sequence screening framework and to leverage the framework for an empirical sensitivity study that measures the impact of ambiguit...